What is PHMB stock price today?

PHMB (Pharmacom Biovet Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PHMB stock going up or down today?

PHMB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PHMB stock now?

The decision to buy PHMB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PHMB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PHMB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PHMB stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PHMB is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PHMB's P/E ratio?

P/E ratio data for PHMB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PHMB's market cap?

PHMB (Pharmacom Biovet Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is PHMB's price to book ratio?

Price-to-book ratio for PHMB is available on our dashboard along with other valuation metrics.

Does PHMB pay dividends?

PHMB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PHMB's dividend yield?

PHMB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PHMB stock a good long-term investment?

PHMB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PHMB's revenue growth rate?

Revenue growth data for PHMB is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PHMB are available on our dashboard with complete income statement analysis.

What are the risks of investing in PHMB?

Key risks for PHMB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PHMB compare to its competitors?

Compare PHMB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHMB's performance and positioning.

What is PHMB's stock price target for 2026?

Our AI model provides price targets for PHMB based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PHMB?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHMB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PHMB's next earnings report?

PHMB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PHMB - Pharmacom Biovet Inc

NYSE * Healthcare * Medical Care Facilities

$0.00

+$0.00 (+0.00%)

About Pharmacom Biovet Inc

PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.

PHMB Key Statistics

Market Cap

$1.08M

How PHMB Compares to Peers

PHMB is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PHMB(This stock)	$1.08M	N/A	0%	0.0%	-
UNHUnitedhealth Group	$285.06B	23.8	0%	0.0%	vs UNH
JNJJohnson &	$575.17B	21.8	0%	0.2%	vs JNJ
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
PFEPfizer Inc	$154.67B	20.0	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$368.65B	87.6	0%	0.1%	vs ABBV

Pharmacom Biovet Inc Company Information

Headquarters: 6040-A Six Forks Road, Raleigh, NC, United States, 27609, undefined
Sector: Healthcare
Industry: Medical Care Facilities

Data Updated: April 17, 2026 at 7:22 AM EDT

Ready to invest in PHMB?

Commission-free trading available. Affiliate links.

Upcoming Events for PHMB

Dashboard

Enter a ticker to analyze